Methamphetamine self-administration acutely decreases monoaminergic transporter function
- PMID: 22120988
- PMCID: PMC3962658
- DOI: 10.1002/syn.21506
Methamphetamine self-administration acutely decreases monoaminergic transporter function
Abstract
Numerous preclinical studies have demonstrated that noncontingent methamphetamine (METH) administration rapidly decreases both dopamine (DA) transporter (DAT) and vesicular monoamine-2 transporter (VMAT-2) function. Because of the importance of transporter function to the abuse and neurotoxic liabilities of METH, and previous research indicating that the effects of noncontingent METH treatment do not necessarily predict effects of contingent exposure, the present study examined the acute impact of METH self-administration on these transporters. Results revealed that five days of METH self-administration (4 h/session; 0.06 mg/infusion) decreased DAT and VMAT-2 activity, as assessed in synaptosomes and vesicles, respectively, prepared from striatal tissue 1 h after the final self-administration session. METH self-administration increased core body temperatures as well. Brain METH and amphetamine (AMPH) levels, assessed 1 h after the final self-administration session, were approximately twice greater in high-pressing rats compared to low-pressing rats despite similar changes in DAT function. In conclusion, the present manuscript is the first to describe transporter function and METH/AMPH levels after self-administration in rodents. These data provide a foundation to investigate complex questions including how the response of dopaminergic systems to METH self-administration contributes to contingent-related processes such as dependence.
Copyright © 2011 Wiley Periodicals, Inc.
Figures
References
-
- Bowyer JF. The role of hyperthermia in amphetamine's interactions with NMDA receptors, nitric oxide, and age to produce neurotoxicity. Ann N Y Acad Sci. 1995;765:309–310. - PubMed
-
- Brennan KA, Colussi-Mas J, Carati C, Lea RA, Fitzmaurice PS, Schenk S. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat. Brain Res. 2010;1317:137–146. - PubMed
-
- Brown JM, Hanson GR, Fleckenstein AE. Methamphetamine rapidly decreases vesicular dopamine uptake. J Neurochem. 2000;74(5):2221–2223. - PubMed
-
- Brown JM, Hanson GR, Fleckenstein AE. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther. 2001;296(3):762–767. - PubMed
-
- Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE. A single methamphetamine administration rapidly decreases vesicular dopamine uptake. J Pharmacol Exp Ther. 2002;302(2):497–501. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA004222/DA/NIDA NIH HHS/United States
- K05 DA000378/DA/NIDA NIH HHS/United States
- 019447/PHS HHS/United States
- 00378/PHS HHS/United States
- P01 DA013367/DA/NIDA NIH HHS/United States
- 11389/PHS HHS/United States
- 00869/PHS HHS/United States
- DA09407/DA/NIDA NIH HHS/United States
- R01 DA011389/DA/NIDA NIH HHS/United States
- 04222/PHS HHS/United States
- 013367/PHS HHS/United States
- R01 DA009407/DA/NIDA NIH HHS/United States
- K02 DA019447/DA/NIDA NIH HHS/United States
- R01 DA000869/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical